findmyKOL
Clinical trialNCT02494024CompletedPhase 1Interventional

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

SponsorC2N DiagnosticsEnrollment32Progressive Supranuclear Palsy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama

    Birmingham, Alabama, United States

  • Mayo Clinic

    Scottsdale, Arizona, United States

  • University of California, Los Angeles (ucla)

    Los Angeles, California, United States

  • Ucsd Department of Neurosciences

    San Diego, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • University of Florida College of Medicine

    Gainesville, Florida, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Indiana University Medical Center

    Indianapolis, Indiana, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Columbia University

    New York, New York, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Texas Health Presbyterian Dallas

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2015
Primary completion
31 Aug 2016
Completion
31 Aug 2016
Last update posted
26 Jul 2017
Registered enrollment
32
Registry id
NCT02494024

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.